Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,088 | 394 | 99.8% |
| Education | $12.80 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $863.74 | 57 | $0 (2024) |
| Merck Sharp & Dohme LLC | $607.61 | 34 | $0 (2024) |
| PFIZER INC. | $389.69 | 25 | $0 (2024) |
| Seagen Inc. | $379.13 | 24 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $352.80 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $348.78 | 19 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $313.11 | 21 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $282.37 | 5 | $0 (2023) |
| Incyte Corporation | $263.41 | 13 | $0 (2024) |
| Lilly USA, LLC | $233.01 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,989 | 99 | Novartis Pharmaceuticals Corporation ($295.78) |
| 2023 | $2,073 | 115 | Novartis Pharmaceuticals Corporation ($332.29) |
| 2022 | $1,736 | 101 | E.R. Squibb & Sons, L.L.C. ($175.62) |
| 2021 | $1,302 | 80 | Novartis Pharmaceuticals Corporation ($131.66) |
All Payment Transactions
395 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Monoclonal Antibody | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Oncology | ||||||
| 12/03/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $23.88 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Oncology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Oncology | ||||||
| 11/13/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: HORMONE THERAPY | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.29 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $3.69 | General |
| Category: Oncology | ||||||
| 09/25/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Monoclonal Antibody | ||||||
| 09/11/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 134 | 156 | $24,977 | $9,028 |
| 2022 | 3 | 195 | 220 | $34,069 | $12,810 |
| 2021 | 4 | 250 | 343 | $54,283 | $22,421 |
| 2020 | 3 | 205 | 250 | $31,804 | $12,065 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 88 | $13,640 | $5,128 | 37.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $6,650 | $2,354 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 43 | $4,687 | $1,547 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 103 | $15,965 | $6,120 | 38.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 34 | 34 | $9,044 | $3,449 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 83 | $9,060 | $3,241 | 35.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 101 | 193 | $28,907 | $12,270 | 42.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 56 | 56 | $14,623 | $6,178 | 42.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 82 | $8,362 | $2,873 | 34.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $2,391 | $1,101 | 46.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 94 | 137 | $17,399 | $6,638 | 38.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 30 | 30 | $7,350 | $3,022 | 41.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 81 | 83 | $7,055 | $2,405 | 34.1% |
About Amanda Young
Amanda Young is a Acute Care healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2015. The National Provider Identifier (NPI) number assigned to this provider is 1982075735.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Young has received a total of $7,100 in payments from pharmaceutical and medical device companies, with $1,989 received in 2024. These payments were reported across 395 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($7,088).
As a Medicare-enrolled provider, Young has provided services to 784 Medicare beneficiaries, totaling 969 services with total Medicare billing of $56,325. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Birmingham, AL
- Active Since 10/19/2015
- Last Updated 10/19/2015
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1982075735
Products in Payments
- KEYTRUDA (Biological) $607.61
- OPDIVO (Biological) $282.53
- BRACANALYSIS CDX (Device) $241.85
- IMBRUVICA (Drug) $229.62
- PADCEV (Biological) $197.44
- ICLUSIG (Drug) $195.77
- SCEMBLIX (Drug) $194.11
- Medline (Device) $168.99
- VERZENIO (Drug) $150.32
- ORGOVYX (Drug) $148.27
- ADCETRIS (Biological) $145.25
- LIBTAYO (Biological) $132.01
- Lenvima (Drug) $126.93
- KISQALI (Drug) $124.88
- IMFINZI (Biological) $124.13
- JAKAFI (Drug) $118.06
- IBRANCE (Drug) $111.24
- XTANDI (Drug) $109.88
- TUKYSA (Drug) $107.75
- Orserdu (Drug) $107.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Birmingham
Shelby Nesbitt
Acute Care — Payments: $11,341
Jonathan Mccrary, Crnp, CRNP
Acute Care — Payments: $11,126
Cameron Stephenson, Np, NP
Acute Care — Payments: $10,840
Melissa French, Crnp, CRNP
Acute Care — Payments: $10,050
Mrs. Jaime Cannon, Crnp, CRNP
Acute Care — Payments: $9,547
Kaci Weaver
Acute Care — Payments: $9,186